Comparing Heart Failure Treatments in Elderly Patients
Hospital Álvaro Cunqueiro, Complexo Hospitalario Universitario de Vigo, IIS Galicia Sur, Spain
2024
n=715
publication
10 minutes
Evidence: moderate
Dobarro David, Raposeiras-Roubin Sergio, Almenar-Bonet Luis, Solé-González Eduard, Padilla-Lopez Mireia, Diez-Lopez Carles, Castrodeza Javier, García-Cosío Maria Dolores, Cobo-Marcos Marta, Tobar Javier, Codina Pau, Lopez-Fernandez Silvia, Pastor Francisco, Rangel-Sousa Diego, Barge-Caballero Eduardo, Diaz-Molina Beatriz, Barrio-Rodriguez Alfredo, Burgos-Palacios Virginia, Álvarez-García Jesús, González-Fernández Oscar, Grau-Sepulveda Andrés, Garcia-Pinilla José Manuel, Ruiz-Bustillo Sonia, Mendez-Fernández Ana B., Vaqueriza-Cubillo David, Sagasti-Aboitiz Igor, Rodriguez-Santamarta Miguel, Lozano-Bahamonde Ainara, Abecia Ana, Gómez-Otero Inés, Marzoa Raquel, González-Babarro Eva, Gómez-Bueno Manuel, Gonzalez-Costello José, Morais João
Title
Comparing Heart Failure Treatments in Elderly Patients
Hypothesis
Is intermittent levosimendan as effective as LVAD therapy for elderly patients with advanced heart failure who are not candidates for heart transplantation?
Conclusion
In elderly patients with advanced heart failure who are not candidates for heart transplantation, LVAD therapy offers significantly better long-term outcomes compared to intermittent levosimendan.